{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T13:39:15Z","timestamp":1774186755784,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.carrev.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T13:45:17Z","timestamp":1552657517000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent"],"prefix":"10.1016","volume":"21","author":[{"given":"Johannes","family":"Waltenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Brachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"van der Heyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Fr\u00f6bert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Seige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrejs","family":"Erglis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hegeler-Molkewehrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Neef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.03.004_bb0005","doi-asserted-by":"crossref","unstructured":"Abizaid A, Costa JR, Jr. New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems. Circ Cardiovasc Interv 2010;3:384\u2013393.","DOI":"10.1161\/CIRCINTERVENTIONS.109.891192"},{"key":"10.1016\/j.carrev.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/eurheartj\/ehn304","article-title":"Biodegradable coating for drug-eluting stents\u2014more than a facelift?","volume":"29","author":"Niemela","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4244\/EIJ-D-17-00557","article-title":"State of the art: coronary artery stents - past, present and future","volume":"13","author":"Stefanini","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.03.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jcin.2018.04.014","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-year outcomes of the randomized BIOFLOW-II trial","volume":"11","author":"Lef\u00e8vre","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.semtcvs.2011.08.001","article-title":"The SYNTAX score and SYNTAX-based clinical risk scores","volume":"23","author":"Farooq","year":"2011","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4244\/EIJV4I4A85","volume":"4","author":"Dahm","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJY15M03_08","article-title":"Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry","volume":"11","author":"Waltenberger","year":"2016","journal-title":"Eurointervention"},{"key":"10.1016\/j.carrev.2019.03.004_bb0050","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in centemporary all-comer stent trials: balancing sensitivity and specificity","volume":"5","author":"Vranckx","year":"2010","journal-title":"Eurointervention"},{"key":"10.1016\/j.carrev.2019.03.004_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1253\/circj.CJ-10-0776","article-title":"Angioscopic assessment of arterial repair following biodegradable polymer-coated biolimus A9-eluting stent implantation - comparison with durable polymer-coated sirolimus-eluting stent","volume":"75","author":"Awata","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/eurheartj\/ehp480","article-title":"An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study","volume":"31","author":"Barlis","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","article-title":"den HP, van der Ent M. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial","volume":"381","author":"Smits","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.03.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003255","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial","volume":"5","author":"Zbinden","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2019.03.004_bb0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.carrev.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4244\/EIJ-D-17-01050","article-title":"Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE\/PROMUS everolimus-eluting stent trial (NEXT)","volume":"14","author":"Natsuaki","year":"2018","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.03.004_bb0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/heartjnl-2016-309283","article-title":"Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients","volume":"103","author":"Danzi","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jcin.2017.02.029","volume":"10","author":"Vlachojannis","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4244\/EIJ-D-17-00529","article-title":"Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent","volume":"13","author":"Meredith","year":"2018","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.03.004_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamacardio.2016.5190","article-title":"Five-year outcome after implantation of zotarolimus- and everolimus-eluting stents in randomized trial participants and nonenrolled eligible patients: a secondary analysis of a randomized clinical trial","volume":"2","author":"von","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.carrev.2019.03.004_bb0120","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4244\/EIJ-D-17-00434","article-title":"Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents","volume":"13","author":"Jakobsen","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.03.004_bb0130","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jjcc.2011.07.003","article-title":"Stent thrombosis and drug-eluting stents","volume":"58","author":"Takayama","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.carrev.2019.03.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002319","article-title":"Clinical outcomes according to diabetic status in patients treated with biodegradable polymer Sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial","volume":"8","author":"Franzone","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0145","article-title":"Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5\u202fyears follow-up","volume":"16","author":"Wiemer","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.carrev.2019.03.004_bb0155","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcin.2009.05.024","article-title":"Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer","volume":"2","author":"Wykrzykowska","year":"2009","journal-title":"The LEADERS trial substudy. JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2016.02.020","article-title":"von BC. Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: insights from 2-year DUTCH PEERS (TWENTE II) randomized trial","volume":"176","author":"van der Heijden","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4070\/kcj.2010.40.5.209","article-title":"Percutaneous recanalization of coronary chronic total occlusions: current devices and specialized wire crossing techniques","volume":"40","author":"Kim","year":"2010","journal-title":"Korean Circ J"},{"key":"10.1016\/j.carrev.2019.03.004_bb0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MCA.0000000000000470","article-title":"Angiographic and clinical outcomes after recanalization of coronary chronic total occlusions with the Orsiro sirolimus-eluting stent compared with the resolute zotarolimus-eluting stent","volume":"28","author":"Markovic","year":"2017","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2019.03.004_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcin.2016.10.017","volume":"10","author":"Teeuwen","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2019.03.004_bb0185","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.4244\/EIJY15M12_09","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction","volume":"12","author":"Pilgrim","year":"2016","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:06Z","timestamp":1761560166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919301666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1553838919301666"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.03.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}